The invention relates to the use of at least one agent for screening out light radiation with a wavelength ranging from 370 to 500 nm as an agent for inhibiting the degradation of endogenous carotenoids present in the skin. The invention is useful for treating skin disorders caused by sunlight (e.g., solar urticaria, actinic dermatitis and pigmentation marks). The invention also relates to novel aminoarylvinyl-s-triazine compounds and to the use thereof as agents for screening out light radiation ranging from 370 to 500 nm.
本发明涉及使用至少一种筛选出波长范围在370至500纳米的光辐射的剂作为抑制皮肤内源类
胡萝卜素降解的剂。本发明可用于治疗由阳光引起的皮肤疾病(例如太阳性荨麻疹、光化性皮炎和色素斑)。本发明还涉及新型
氨基芳基
乙烯基-s-三嗪化合物及其作为筛选出波长范围在370至500纳米的光辐射的剂的用途。